HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$0.24
Day range
$0.22 - $0.25
Year range
$0.15 - $3.10
Market cap
1.24M USD
Avg Volume
4.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.73M | 10.74% |
Net income | -2.73M | -13.46% |
Net profit margin | — | — |
Earnings per share | -0.74 | 90.91% |
EBITDA | -2.73M | -10.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.19M | -74.69% |
Total assets | 3.23M | -44.19% |
Total liabilities | 1.53M | 92.24% |
Total equity | 1.70M | — |
Shares outstanding | 5.27M | — |
Price to book | 0.52 | — |
Return on assets | -167.33% | — |
Return on capital | -244.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.73M | -13.46% |
Cash from operations | -2.25M | -5.83% |
Cash from investing | 0.00 | — |
Cash from financing | 547.58K | 1,889.07% |
Net change in cash | -1.70M | 21.09% |
Free cash flow | 45.61K | -6.00% |
About
Founded
2011
Headquarters
Website
Employees
10
